General Information of Drug Therapeutic Target (DTT) (ID: TT4ILYC)

DTT Name Bacterial Dihydropteroate synthetase (Bact folP)
Synonyms folP; H2Pte synthase; Dihydropteroate synthase; Dihydropteroate pyrophosphorylase; DHPS
Gene Name Bact folP
DTT Type
Successful target
[1]
BioChemical Class
Alkyl aryl transferase
UniProt ID
DHPS_ECOLI
TTD ID
T88240
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
EC 2.5.1.15
Sequence
MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINAGATIIDVGGE
STRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRESAKVGAHIINDIRSL
SEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEQAGIAKE
KLLLDPGFGFGKNLSHNYSLLARLAEFHHFNLPLLVGMSRKSMIGQLLNVGPSERLSGSL
ACAVIAAMQGAHIIRVHDVKETVEAMRVVEATLSAKENKRYE
Function Dhps catalyzes the formation of the immediate precursor of folic acid. It is implicated in resistance to sulfonamide.
KEGG Pathway
Folate biosynthesis (ecj00790 )
Metabolic pathways (ecj01100 )
Biosynthesis of cofactors (ecj01240 )
BioCyc Pathway
MetaCyc:H2PTEROATESYNTH-MON
EcoCyc:H2PTEROATESYNTH-MON

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
22 Approved Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cefozopran DMKBTFG Gram-positive bacterial infection 1B74-1G40 Approved [1]
Chlorhexidine DMQ9MVG Bacterial infection 1A00-1C4Z Approved [2]
Colistimethate DMZ9BMU Respiratory tract infection CA45 Approved [3]
Colistin DMMD9QE Pseudomonas infection 1B92 Approved [3]
Daptomycin DMFDQ3I Bacterial infection 1A00-1C4Z Approved [4]
Doripenem DM9UCJK Cholecystitis Approved [1]
Faropenem DMX7A5V Gram-positive bacterial infection 1B74-1G40 Approved [1]
Gramicidin D DMPT74U Bacterial infection 1A00-1C4Z Approved [5]
Oritavancin DM28D05 Bacterial infection 1A00-1C4Z Approved [1]
Polymyxin B Sulfate DMN0LP8 Bacteremia 1A73 Approved [3]
Silver sulfadiazine DMVTHWQ Bacterial infection 1A00-1C4Z Approved [6]
Sulfacytine DMKI2XC Cystitis GC00 Approved [7]
Sulfadiazine DMTW3R8 Rheumatic fever 1B40-1B42 Approved [8]
Sulfamerazine DMKM3SX Bacterial infection 1A00-1C4Z Approved [9]
Sulfamethazine DMRGZ16 Bacterial infection 1A00-1C4Z Approved [10]
Sulfamethizole DMGCHDS Acute otitis media AB00 Approved [11]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [12]
Sulfanilamide DMABVE9 Bacterial infection 1A00-1C4Z Approved [13]
Sulfapyridine DMIUYFH Dermatitis herpetiformis EB44 Approved [9]
Sulfisoxazole DMXLT8C Acute otitis media AB00 Approved [14]
Sulfonamides DM1YA7M Bacterial infection 1A00-1C4Z Approved [15]
Sulphadoxine DMZI2UF Malaria 1F40-1F45 Approved [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 22 Approved Drug(s)
1 Discontinued Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulfametopyrazine DMBCK2S Urinary tract infection GC08 Withdrawn from market [17]
------------------------------------------------------------------------------------
9 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
2,6-diamino-5-nitropyrimidin-4(3H)-one DMREF31 Discovery agent N.A. Investigative [18]
2,6-diamino-5-nitrosopyrimidin-4(3H)-one DM4RS9N Discovery agent N.A. Investigative [18]
2-amino-8-methyl-7,8-dihydropteridin-4(3H)-one DMRSGC5 Discovery agent N.A. Investigative [18]
6-Methylamino-5-Nitroisocytosine DMN6IDK Discovery agent N.A. Investigative [19]
Ethylene diamine DMBULX4 Tuberculosis 1B10-1B1Z Investigative [20]
HKI-9924129 DM5LR2B Gram-positive bacterial infection 1B74-1G40 Investigative [1]
Pterin-6-Yl-Methyl-Monophosphate DM98IOX Discovery agent N.A. Investigative [21]
Pteroic Acid DMT2YNG Discovery agent N.A. Investigative [22]
[Pterin-6-Yl Methanyl]-Phosphonophosphate DM4ZY79 Discovery agent N.A. Investigative [21]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Investigative Drug(s)

References

1 Emerging drugs for bacterial urinary tract infections. Expert Opin Emerg Drugs. 2005 May;10(2):275-98.
2 The mechanism of action of chlorhexidine. FEMS Microbiol Lett. 1992 Dec 15;79(1-3):211-5.
3 Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother. 1999 Sep;33(9):960-7.
4 Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem Biol. 2004 Jul;11(7):949-57.
5 Structures of gramicidins A, B, and C incorporated into sodium dodecyl sulfate micelles. Biochemistry. 2001 Oct 2;40(39):11676-86.
6 Comparative evaluation of transdermal formulations of norfloxacin with silver sulfadiazine cream, USP, for burn wound healing property. J Burns Wounds. 2006 Jun 7;5:e4.
7 Sulfacytine in uncomplicated urinary tract infections. Double-blind comparison with sulfisoxazole. Urology. 1976 Mar;7(3):267-71.
8 Sulfadiazine/hydroxypropyl-beta-cyclodextrin host-guest system: Characterization, phase-solubility and molecular modeling. Bioorg Med Chem. 2008 May 15;16(10):5788-94.
9 A confirmatory method for the simultaneous extraction, separation, identification and quantification of Tetracycline, Sulphonamide, Trimethoprim an... J Chromatogr A. 2009 Nov 13;1216(46):8110-6.
10 A new and simple method to determine trace levels of sulfonamides in honey by high performance liquid chromatography with fluorescence detection. J Chromatogr A. 2009 Oct 23;1216(43):7275-80.
11 Inhibition of bioluminescence in Photobacterium phosphoreum by sulfamethizole and its stimulation by thymine. Biochim Biophys Acta. 1990 Jun 26;1017(3):229-34.
12 In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs. Antimicrob Agents Chemother. 1995 Apr;39(4):948-52.
13 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
14 Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob Agents Chemother. 1995 Aug;39(8):1756-63.
15 Has nature already identified all useful antibacterial targets Curr Opin Microbiol. 2008 Oct;11(5):387-92.
16 The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs. Curr Med Chem. 2008;15(2):161-71.
17 Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study. Indian J Malariol. 2001 Sep-Dec;38(3-4):76-83.
18 Structural studies of pterin-based inhibitors of dihydropteroate synthase. J Med Chem. 2010 Jan 14;53(1):166-77.
19 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
20 Novel agents in the management of Mycobacterium tuberculosis disease. Curr Med Chem. 2007;14(18):2000-8.
21 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
22 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.